查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625408

對乙醯氨基酚靜脈注射市場規模、佔有率、趨勢、行業分析報告（按適應症、應用、最終用途和地區）- 市場預測，2025-2034 年

Paracetamol IV Market Size, Share, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，靜脈注射對乙醯氨基酚市場規模預計到 2034 年將達到 11.1785 億美元。該研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

靜脈注射對乙醯氨基酚市場的擴張是由對有效疼痛管理解決方案的不斷增長的需求推動的，特別是在快速起效至關重要的臨床環境中。市場需求很大程度上是由人們對靜脈注射製劑而非口服製劑的偏好所支持的，尤其是對於口服給藥困難的患者而言。外科手術增多、需要術後止痛的慢性病發生率增加、老年人口不斷增加等因素促使靜脈注射對乙醯氨基酚的需求不斷增加。全球醫療保健基礎設施的擴張極大地推動了靜脈注射對乙醯氨基酚市場的成長。

靜脈注射對乙醯氨基酚市場的前景無疑是光明的，藥物輸送方面的突破性創新和配方技術的改進提供了巨大的市場機會，確保對乙醯氨基酚的靜脈注射對不同患者群體更安全、更有效。此外，靜脈注射對乙醯氨基酚市場的擴張得到了領先產業參與者對研發的策略投資的支持。這些投資主要集中在最大程度提高產品的功效和安全性，同時最大程度減少副作用，鞏固靜脈注射對乙醯氨基酚作為疼痛管理方案中更好選擇的地位。

對乙醯氨基酚靜脈注射市場報告重點

在 2024 年的對乙醯氨基酚靜脈注射市場中，由於對手術和創傷後有效和立即緩解疼痛的需求很高，預計疼痛部分將佔據主要佔有率（基於適應症）。

根據最終用途，診所部分預計將在預測期內實現最高的複合年增長率，這歸因於人們對門診護理的偏好日益增加以及診所中靜脈疼痛管理選項的可用性不斷增加。

由於整個地區都重視有效的疼痛管理，到 2024 年，北美將佔據靜脈注射對乙醯氨基酚市場的主導地位。

由於醫療保健投資的增加，預計亞太市場在預測期內將顯著成長。

全球市場的主要參與者包括 Mallinckrodt（Mallinckrodt Pharmaceuticals）、Cipla Inc.、Lupin、Dr Reddy's Laboratories Ltd.、Aurobindo Pharma、Sun Pharmaceutical Industries Limited、Novartis AG、Pfizer Inc.、Abbott、Sanofi、Bristol-Myers Squibb Company 等。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章。
  • 市場概況
  • 對乙醯氨基酚靜脈注射劑市場動態
    • 推動因素和機遇
      • 手術程序增加
      • 慢性疼痛和發燒加劇
    • 阻礙因素和課題
      • 替代藥物選擇
  • PESTEL 分析
  • 對乙醯氨基酚靜脈注射劑市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

5. 全球靜脈注射對乙醯氨基酚市場（依適應症劃分）

  • 主要發現
  • 簡介
  • 痛苦
  • 發燒

6. 全球對乙醯氨基酚注射劑市場（依應用）

  • 主要發現
  • 簡介
  • 手術
  • 非手術

7. 全球靜脈注射對乙醯氨基酚市場（依最終用途劃分）

  • 主要發現
  • 簡介
  • 醫院
  • 診所
  • 其他

8. 全球靜脈注射對乙醯氨基酚市場（按地區）

  • 主要發現
  • 簡介
    • 2020 年至 2034 年對乙醯氨基酚靜脈注射劑市場各地區評估
  • 北美洲
    • 北美，依適應症分類，2020 年至 2034 年
    • 2020 年至 2034 年北美各應用領域
    • 2020 年至 2034 年，北美以最終用途劃分
    • 美國
    • 加拿大
  • 歐洲
      2020 年至 2034 年歐洲各適應症 2020 年至 2034 年歐洲應用狀況 2020 年至 2034 年歐洲最終用途狀況
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
      亞太地區，依適應症，2020 年至 2034 年 2020 年至 2034 年亞太地區應用情況 2020 年至 2034 年亞太地區最終用途
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
      2020 年至 2034 年中東及非洲各指標 2020 年至 2034 年中東和非洲的應用狀況
    • 2020 年至 2034 年中東和非洲依最終用途劃分
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 2020 年至 2034 年拉丁美洲依適應症劃分的情況
    • 2020 年至 2034 年拉丁美洲各應用領域狀況
    • 2020 年至 2034 年拉丁美洲依最終用途劃分
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 9 章 競爭格局

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第十章 公司簡介

  • Mallinckrodt（Mallinckrodt Pharmaceuticals）
  • Cipla Inc.
  • Lupin
  • Dr Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Limited
  • Novartis AG
  • Pfizer Inc.
  • Abbott
  • Sanofi
  • Bristol-Myers Squibb Company
Product Code: PM5289

The paracetamol IV market size is expected to reach USD 1,117.85 million by 2034, according to a new study by Polaris Market Research. The report "Paracetamol IV Market Share, Size, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for effective pain management solutions, particularly in clinical settings where rapid onset is crucial, drives the paracetamol IV market expansion. The preference for intravenous (IV) formulations over oral routes, especially for patients unable to take medication orally, significantly supports market demand. Factors such as increasing surgical procedures, a growing prevalence of chronic conditions requiring postoperative pain relief, and the expanding geriatric population contribute to the rising need for paracetamol IV formulations. The global expansion of healthcare infrastructure is significantly propelling the paracetamol IV market growth, as more hospitals and clinics are becoming equipped to provide IV pain management.

The paracetamol IV market outlook is undeniably positive, with significant market opportunities fueled by groundbreaking innovations in drug delivery and enhanced formulation techniques that ensure intravenous (IV) paracetamol is both safer and more effective for diverse patient groups. Furthermore, the IV paracetamol market expansion is supported by strategic investments in research and development from leading industry players. These investments are specifically geared toward maximizing product efficacy and safety while minimizing side effects, firmly establishing IV paracetamol as a better option in pain management protocols.

Paracetamol IV Market Report Highlights

In terms of indication, in 2024, the pain segment accounted for a larger share of the paracetamol IV market revenue due to the high demand for effective and immediate pain relief in post-surgical and trauma cases.

The clinics segment, based on end use, is expected to witness the highest CAGR during the forecast period due to the growing preference for outpatient care and the increasing availability of intravenous pain management options in clinic settings.

In 2024, North America dominated the paracetamol IV market share due to the strong focus on effective pain management practices across the region.

The Asia Pacific market is expected to witness significant growth during the forecast period due to increasing healthcare investments.

A few global key market players are Mallinckrodt (Mallinckrodt Pharmaceuticals), Cipla Inc., Lupin, Dr Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., Abbott, Sanofi, and Bristol-Myers Squibb Company.

Polaris Market Research has segmented the paracetamol IV market report on the basis of indication, application, end use, and region:

By Indication Outlook (Revenue, USD Million; 2020-2034)

  • Pain
  • Pyrexia

By Application Outlook (Revenue, USD Million; 2020-2034)

  • Surgical
  • Non-Surgical

By End Use Outlook (Revenue, USD Million; 2020-2034)

  • Hospitals
  • Clinics
  • Others

By Regional Outlook (Revenue, USD Million; 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Paracetamol IV Market Insights

  • 4.1. Paracetamol IV Market - Market Snapshot
  • 4.2. Paracetamol IV Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Surgical Procedures
      • 4.2.1.2. Rising Prevalence of Chronic Pain and Fever
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Alternative Drug Option
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Paracetamol IV Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Paracetamol IV Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
  • 5.3. Pain
    • 5.3.1. Global Paracetamol IV Market, by Pain, by Region, 2020-2034 (USD Million)
  • 5.4. Pyrexia
    • 5.4.1. Global Paracetamol IV Market, by Pyrexia, by Region, 2020-2034 (USD Million)

6. Global Paracetamol IV Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Paracetamol IV Market, by Application, 2020-2034 (USD Million)
  • 6.3. Surgical
    • 6.3.1. Global Paracetamol IV Market, by Surgical, by Region, 2020-2034 (USD Million)
  • 6.4. Non-surgical
    • 6.4.1. Global Paracetamol IV Market, by Non-surgical, by Region, 2020-2034 (USD Million)

7. Global Paracetamol IV Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Hospital
    • 7.3.1. Global Paracetamol IV Market, by Hospital, by Region, 2020-2034 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Global Paracetamol IV Market, by Clinics, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Paracetamol IV Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Paracetamol IV Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Paracetamol IV Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Paracetamol IV Market - North America
    • 8.3.1. North America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.3.2. North America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Paracetamol IV Market - U.S.
      • 8.3.4.1. U.S.: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Paracetamol IV Market - Canada
      • 8.3.5.1. Canada: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Paracetamol IV Market - Europe
    • 8.4.1. Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.4.2. Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Paracetamol IV Market - UK
      • 8.4.4.1. UK: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Paracetamol IV Market - France
      • 8.4.5.1. France: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.5.2. France: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Paracetamol IV Market - Germany
      • 8.4.6.1. Germany: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Paracetamol IV Market - Italy
      • 8.4.7.1. Italy: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Paracetamol IV Market - Spain
      • 8.4.8.1. Spain: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Paracetamol IV Market - Netherlands
      • 8.4.9.1. Netherlands: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Paracetamol IV Market - Russia
      • 8.4.10.1. Russia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Paracetamol IV Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Paracetamol IV Market - Asia Pacific
    • 8.5.1. Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Paracetamol IV Market - China
      • 8.5.4.1. China: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.4.2. China: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Paracetamol IV Market - India
      • 8.5.5.1. India: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.5.2. India: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Paracetamol IV Market - Malaysia
      • 8.5.6.1. Malaysia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Paracetamol IV Market - Japan
      • 8.5.7.1. Japan: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Paracetamol IV Market - Indonesia
      • 8.5.8.1. Indonesia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Paracetamol IV Market - South Korea
      • 8.5.9.1. South Korea: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Paracetamol IV Market - Australia
      • 8.5.10.1. Australia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Paracetamol IV Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Paracetamol IV Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Paracetamol IV Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Paracetamol IV Market - UAE
      • 8.6.5.1. UAE: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Paracetamol IV Market - Israel
      • 8.6.6.1. Israel: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Paracetamol IV Market - South Africa
      • 8.6.7.1. South Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Paracetamol IV Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Paracetamol IV Market - Latin America
    • 8.7.1. Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Paracetamol IV Market - Mexico
      • 8.7.4.1. Mexico: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Paracetamol IV Market - Brazil
      • 8.7.5.1. Brazil: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Paracetamol IV Market - Argentina
      • 8.7.6.1. Argentina: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Paracetamol IV Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Mallinckrodt (Mallinckrodt Pharmaceuticals)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Cipla Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Lupin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr Reddy's Laboratories Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Aurobindo Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sun Pharmaceutical Industries Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Abbott
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Bristol-Myers Squibb Company
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

Table 1 Global Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 2 Global Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 3 Global Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 4 North America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 5 North America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 6 North America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 7 U.S.: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 8 U.S.: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 9 U.S.: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 10 Canada: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 11 Canada: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 12 Canada: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 13 Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 14 Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 15 Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 16 UK: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 17 UK: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 18 UK: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 19 France: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 20 France: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 21 France: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 22 Germany: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 23 Germany: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 24 Germany: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 25 Italy: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 26 Italy: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 27 Italy: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 28 Spain: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 29 Spain: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 30 Spain: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 31 Netherlands: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 32 Netherlands: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 33 Netherlands: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 34 Russia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 35 Russia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 36 Russia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 37 Rest of Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 38 Rest of Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 39 Rest of Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 40 Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 41 Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 42 Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 43 China: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 44 China: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 45 China: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 46 India: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 47 India: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 48 India: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 49 Malaysia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 50 Malaysia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 51 Malaysia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 52 Japan: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 53 Japan: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 54 Japan: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 55 Indonesia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 56 Indonesia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 57 Indonesia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 58 South Korea: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 59 South Korea: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 60 South Korea: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 61 Australia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 62 Australia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 63 Australia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 64 Rest of Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 65 Rest of Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 66 Rest of Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 67 Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 68 Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 69 Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 70 Saudi Arabia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 71 Saudi Arabia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 72 Saudi Arabia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 73 UAE: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 74 UAE: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 75 UAE: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 76 Israel: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 77 Israel: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 78 Israel: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 79 South Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 80 South Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 81 South Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 82 Rest of Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 83 Rest of Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 84 Rest of Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 85 Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 86 Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 87 Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 88 Mexico: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 89 Mexico: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 90 Mexico: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 91 Brazil: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 92 Brazil: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 93 Brazil: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 94 Argentina: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 95 Argentina: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 96 Argentina: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 97 Rest of Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 98 Rest of Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 99 Rest of Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Paracetamol IV Market, 2020-2034 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Indication

Figure 7. Global Paracetamol IV Market, by Indication, 2024 & 2034 (USD Million)

Figure 8. Market by Application

Figure 9. Global Paracetamol IV Market, by Application, 2024 & 2034 (USD Million)

Figure 10. Market by End Use

Figure 11. Global Paracetamol IV Market, by End Use, 2024 & 2034 (USD Million)